We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene-Sequence Scanner Analyzes More Data

By HospiMedica staff writers
Posted on 11 Jul 2005
The new GeneChip scanner (GCS) 3000 7G allows the analysis of microarrays that feature 500% more data than previous generations.

With the ability to scan smaller features, ranging in size from 2.5 µm to 0.51 µm, the new scanner supports the latest high-density GeneChip microarrays for tiling, all-exon, and single nucleotide polymorphism (SNP) genotyping research. More...
The new scanner is the product of Affymetrix, Inc. (Santa Clara, CA, USA). It is designed to provide peak scanning performance for all operations, including RNA expression and DNA analysis. The scanner is compatible with data from previous experiments using GeneChip microarrays as well as other instruments and software of Affymetrix.

Specific features of the GCS 3000 7G include a new dual processor workstation and software updates for processing and analyzing up to five times as much data per experiment, and an improved autofocus algorithm for scanning standard-size 49-format microarrays 30% faster than the original GSC. In addition, a patented scanning system called the Flying Objective provides image uniformity and accuracy. High-numerical-
aperture optical architecture provides consistent excitation and emission paths over the entire scan field.

"We designed the original GCS 3000 to be forward-compatible, requiring only a simple upgrade to support the next-generation of high-density microarrays that develop as GeneChip technology continues to advance,” observed Chip Leveille, vice president of Product Technologies Group, Affymetrix.




Related Links:
Affymetrix

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.